Ori Liraz

625 total citations
15 papers, 470 citations indexed

About

Ori Liraz is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Ori Liraz has authored 15 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 9 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Ori Liraz's work include Alzheimer's disease research and treatments (10 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Ori Liraz is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Neuroscience and Neuropharmacology Research (3 papers). Ori Liraz collaborates with scholars based in Israel, United States and Czechia. Ori Liraz's co-authors include Daniel M. Michaelson, Anat Boehm‐Cagan, Jan O. Johansson, John K. Bielicki, Usha Gundimeda, Shaowei Wang, Hussein N. Yassine, Chongren Tang, Jian Sima and Helena C. Chui and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Journal of Neurochemistry.

In The Last Decade

Ori Liraz

15 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ori Liraz Israel 10 308 169 105 99 82 15 470
Anat Boehm‐Cagan Israel 8 288 0.9× 155 0.9× 105 1.0× 86 0.9× 76 0.9× 11 421
Steve Estus United States 6 366 1.2× 204 1.2× 114 1.1× 49 0.5× 86 1.0× 9 526
Helen K. Warwick United Kingdom 4 249 0.8× 218 1.3× 138 1.3× 68 0.7× 38 0.5× 5 477
Hyang-Sook Hoe United States 3 308 1.0× 198 1.2× 131 1.2× 61 0.6× 55 0.7× 3 446
Wenxin Yu Japan 6 314 1.0× 224 1.3× 79 0.8× 61 0.6× 54 0.7× 8 523
Tien‐Phat V. Huynh United States 6 360 1.2× 154 0.9× 95 0.9× 41 0.4× 71 0.9× 8 475
Zhong‐Chen Wu China 15 408 1.3× 320 1.9× 90 0.9× 63 0.6× 49 0.6× 20 682
Evelyn Nwabuisi‐Heath United States 6 489 1.6× 196 1.2× 167 1.6× 51 0.5× 92 1.1× 6 630
Tomonori Aikawa United States 9 187 0.6× 190 1.1× 78 0.7× 60 0.6× 25 0.3× 12 401
Jean‐Michel Itier France 6 383 1.2× 276 1.6× 149 1.4× 157 1.6× 76 0.9× 6 656

Countries citing papers authored by Ori Liraz

Since Specialization
Citations

This map shows the geographic impact of Ori Liraz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ori Liraz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ori Liraz more than expected).

Fields of papers citing papers by Ori Liraz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ori Liraz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ori Liraz. The network helps show where Ori Liraz may publish in the future.

Co-authorship network of co-authors of Ori Liraz

This figure shows the co-authorship network connecting the top 25 collaborators of Ori Liraz. A scholar is included among the top collaborators of Ori Liraz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ori Liraz. Ori Liraz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Liraz, Ori, et al.. (2024). The Role of Impaired Receptor Trafficking in Mediating the Pathological Effects of APOE4 in Alzheimer’s Disease. Journal of Alzheimer s Disease. 97(2). 753–775. 2 indexed citations
2.
Liraz‐Zaltsman, Sigal, Daniel M. Michaelson, Ori Liraz, et al.. (2023). 9-cis beta-carotene-enriched diet significantly improved cognition and decreased Alzheimer’s disease neuropathology and neuroinflammation in Alzheimer’s disease-like mouse models. Neurobiology of Aging. 133. 16–27. 5 indexed citations
3.
Liraz, Ori, et al.. (2019). ApoE4 Exacerbates Hippocampal Pathology Following Acute Brain Penetration Injury in Female Mice. Journal of Molecular Neuroscience. 70(1). 32–44. 7 indexed citations
4.
Rawat, Varun, Shaowei Wang, Jian Sima, et al.. (2019). ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes. Journal of Neuroscience. 39(48). 9611–9622. 105 indexed citations
5.
Liraz, Ori, et al.. (2016). An Anti-apoE4 Specific Monoclonal Antibody Counteracts the Pathological Effects of apoE4 In Vivo. Current Alzheimer Research. 13(8). 918–929. 25 indexed citations
6.
Barhum, Yael, Anat Boehm‐Cagan, Ori Liraz, et al.. (2016). Reversal of ApoE4-Driven Brain Pathology by Vascular Endothelial Growth Factor Treatment. Journal of Alzheimer s Disease. 53(4). 1443–1458. 28 indexed citations
7.
Boehm‐Cagan, Anat, et al.. (2016). ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies. Journal of Alzheimer s Disease. 54(3). 1219–1233. 89 indexed citations
8.
Liraz, Ori, Yael Nisgav, Tami Livnat, et al.. (2015). The effects of the apoE4 genotype on the developing mouse retina. Experimental Eye Research. 145. 17–25. 6 indexed citations
9.
Liraz, Ori, et al.. (2015). Apolipoprotein E4 reduces evoked hippocampal acetylcholine release in adult mice. Journal of Neurochemistry. 136(3). 503–509. 21 indexed citations
10.
Liraz, Ori, et al.. (2015). Behavioral testing affects the phenotypic expression of APOE ε3 and APOE ε4 in targeted replacement mice and reduces the differences between them. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 1(2). 127–135. 10 indexed citations
11.
Boehm‐Cagan, Anat, et al.. (2014). Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo. Current Alzheimer Research. 11(6). 549–557. 26 indexed citations
12.
Boehm‐Cagan, Anat, et al.. (2013). Hippocampus-Related Cognitive Impairments in Young apoE4 Targeted Replacement Mice. Neurodegenerative Diseases. 13(2-3). 86–92. 30 indexed citations
13.
Liraz, Ori, Anat Boehm‐Cagan, & Daniel M. Michaelson. (2013). ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice. Molecular Neurodegeneration. 8(1). 16–16. 97 indexed citations
14.
Liraz, Ori, et al.. (2012). The Effects of Apolipoproteins E3 and E4 on the Transforming Growth Factor-β System in Targeted Replacement Mice. Neurodegenerative Diseases. 10(1-4). 41–45. 11 indexed citations
15.
Liraz, Ori, Kobi Rosenblum, & Edi Barkai. (2009). CAMKII Activation Is Not Required for Maintenance of Learning-Induced Enhancement of Neuronal Excitability. PLoS ONE. 4(1). e4289–e4289. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026